• Explore /
  • Poster
  • / A phase II single-arm trial of niraparib in platinum-sensitive metastatic castration-resistant prostate cancer with DNA repair defects (PLATPARP).

A phase II single-arm trial of niraparib in platinum-sensitive metastatic castration-resistant prostate cancer with DNA repair defects (PLATPARP).

Abstract Poster

Authors

Vivek Narayan

Vivek Narayan

University of Pennsylvania, Philadelphia, PA

Vivek Narayan , Alexandra Torres , Philip Seger , Megan Aaron , Jennifer Louie , Daniel Lee , Naomi B. Haas , Samuel U Takvorian , Kara Noelle Maxwell , Susan M. Domchek

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2023 ASCO Genitourinary Cancers Symposium

Session Type

Trials in Progress Poster Session

Session Title

Trials in Progress Poster Session A: Prostate Cancer

Track

Prostate Cancer - Advanced,Prostate Cancer - Localized

Sub Track

Therapeutics

Clinical Trial Registration Number

NCT04288687

Citation

J Clin Oncol 41, 2023 (suppl 6; abstr TPS291)

DOI

10.1200/JCO.2023.41.6_suppl.TPS291

Abstract #

TPS291

Poster Bd #

Q13

Abstract Disclosures

Similar Posters

First Author: Anup Kasi

First Author: Qiuxiang Ou

First Author: Severine Guiu Lahaye

First Author: Yasser Ged